Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology

Annual Review of Cell and Developmental Biology

Volumn 12, Issue , 1996, Pages 335-363

  Lemberger, Thomas ^a   Desvergne, Béatrice ^a   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

adipocyte differentiation; fatty acids; insulin resistance; prostaglandins; transcription

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CELL NUCLEUS RECEPTOR; CYCLOPENTANONE DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PEROXISOME PROLIFERATOR; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RECEPTOR; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR;

ADIPOCYTE; BINDING AFFINITY; CELL DIFFERENTIATION; CHROMOSOMAL LOCALIZATION; DNA BINDING; FATTY ACID METABOLISM; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIGAND BINDING; LIPID METABOLISM; LIVER METABOLISM; NONHUMAN; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; LIPIDS; MICROBODIES; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0029731662     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.12.1.335     Document Type: Review

References (116)

1. Aldridge TC, Tugwood JD, Green S. 1995. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Binchem. J. 306:473-79
2. Amri EZ, Bonino F, Ailhaud G, Abumrad NA, Grimaldi PA. 1995. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. J. Biol. Chem. 270:2367-71
3. Aperlo C, Pognonec P, Saladin R, Auwerx J, Boulukos KE. 1995. cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPAR-gamma. Gene 162:297-302
4. Baes M, Castelein H, Desmet L, Declercq PE. 1995. Antagonism of COUP-TF and PPAR-alpha/RXR-alpha on the activation of the malic enzyme gene promoter: modulation by 9-cis RA. Biochem. Biophys. Res. Commun. 215:338-45
5. Björntorp P. 1991. Metabolic implications of body fat distribution. Diabetes Care 14: 1132-43
6. Blackmore PF, McPherson RK, Stevenson RW. 1993. Actions of the novel antidiabetic agent englitazone in rat hepatocytes. Metabolism 42:1583-87
7. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR alpha. Nature 375:377-82
8. Brady PS, Marine KA, Brady LJ, Ramsay RR. 1989. Co-ordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs. Biochem. J. 260:93-100
9. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR alpha, beta and gamma in the adult rat. Endocrinology 137:354-66
10. Cao ZD, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538-52
11. Castelein H, Gulick T, Declercq PE, Mannaerts GP, Moore DD, Baes MI. 1994. The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J. Biol. Chem. 269:26754-58
12. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. 1994. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135:798-800
13. Chen F, Law SW, O'Malley BW. 1993. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochem. Biophys. Res. Commun. 196:671-77
14. Chu RY, Madison LD, Lin YL, Kopp P, Rao MS, et al. 1995. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc. Natl. Acad. Sci. USA 92:11593-97
15. Desvergne B, Wahli W. 1995. PPAR: a key nuclear factor in nutrient/gene interactions? In Inducible Transcriptions, ed. P Baeuerle, 1:142-76. Boston: Birkhaüser
16. Dreyer C, Keller H, Mahfoudi A, Laudet V, Krey G, Wahli W. 1993. Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell 77:67-76
17. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. 1992. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68:879-87
18. el-Kebbi IM, Roser S, Pollet RJ. 1994. Regulation of glucose transport by pioglitazone in cultured muscle cells. Metabolism 43:953-58
19. Feng JQ, Chen D, Cooney AJ, Tsai MJ, Harris MA, et al. 1995. The mouse bone morphogenetic protein-4 gene. Analysis of promoter utilization in fetal rat calvarial osteoblasts and regulation by COUP-TFI orphan receptor. J. Biol. Chem. 270:28364-73
20. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 1995. 15-deoxy-delta (12,14)-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-gamma. Cell 83:803-12
21. Foxworthy PS, Eacho PI. 1991. Effect of the peroxisome proliferator LY171883 on triglyceride accumulation in rats fed a fat-free diet. Biochem. Pharmacol. 42:1487-91
22. Foxworthy PS, Perry DN, Hoover DM, Eacho PI. 1990. Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883. Toxicol. Appl. Pharmacol. 106:375-83
23. Freytag SO, Paielli DL, Gilbert JD. 1994. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8:1654-63
24. Fukushima M. 1990. Prostaglandin J2 - anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids 3:189-99
25. Fukushima M. 1992. Biological activities and mechanisms of action of PGJ2 and related compounds : an update. Prostaglandins Leuk. Essential Fatty Acids 47:1-12
26. Gearing KL, Crickmore A, Gustafsson JÅ. 1994. Structure of the mouse peroxisome proliferator activated receptor alpha gene. Biochem. Biophys. Res. Commun. 199:255-63
27. Gearing KL, Go̊ttlicher M, Teboul M, Widmark E, Gustafsson JÅ. 1993. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA 90:1440-44
28. Glass CK. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15:391-407
29. Goetzl EJ, An S, Smith WL. 1995. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J. 9:1051-58
30. Göttlicher M, Demoz A, Svensson D, Toilet P, Berge RK, Gustafsson JÅ. 1993. Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem. Pharmacol. 46:2177-84
31. Göttlicher M, Widmark E, Li Q, Gustafsson JÅ. 1992. Fatty acids activate a chimera of the clonbric acid-activated receptor and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA 89:4653-57
32. Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, et al. 1995. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Exp. 4:281-99
33. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP. 1994. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. USA 91:11012-16
34. Härd T, Kellenbach E, Boelens R, Maler BA, Dahlman K, et al. 1990. Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249:157-60
35. Hertz R, Bishara-Shieban J, Bar-Tana J. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270:13470-75
36. Hirata Y, Hayashi H, Ito S, Kikawa Y, Ishibashi M, et al. 1988. Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine. J. Biol. Chem. 263:16619-25
37. Hofmann CA, Colca JR. 1992. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care 15:1075-78
38. Hofmann CA, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, et al. 1994. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-70
39. Hu ED, Tontonoz P, Spiegelman BM. 1995. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR-gamma and C/EBP-alpha. Proc. Natl. Acad. Sci. USA 92:9856-60
40. Ibrahimi A, Teboul L, Gaillard D, Amri EZ, Ailhaud G, et al. 1994. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells. Mol. Pharmacol. 46:1070-76
41. Issemann I, Green S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-50
42. Jones PS, Savory R, Barratt P, Bell AR, Gray T, et al. 1995. Chromosomal localisation, inducibility, tissue-specific expression and strain differences in three murine peroxisome-proliferator-activated-receptor genes. Eur. J. Biochem. 233:219-26
43. Jow L, Mukherjee R. 1995. The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPAR alpha and thyroid hormone receptors. J. Biol. Chem. 270:3836-40
44. Juge-Aubry CE, Gorla-Bajszczak A, Pernin A, Lemberger T, Wahli W, et al. 1995. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat. J. Biol. Chem. 270:18117-22
45. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, et al. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127:1755-66
46. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W. 1993a. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA 90:2160-64
47. Keller H, Mahfoudi A, Dreyer C, Hihi AK, Medin J, et al. 1993b. Peroxisome proliferator-activated receptors and lipid metabolism. Ann. NY Acad. Sci. 684:157-73
48. Kletzien RF, Clarke SD, Ulrich RG. 1992. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol. Pharmacol. 41:393-98
49. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, et al. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91:7355-59
50. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-19
51. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358:771-74
52. Koshihara Y, Takamori R, Nomura K, Sugiura S, Kurozumi S. 1991. Enhancement of in vitro mineralization in human osteoblasts by a novel prostaglandin A1 derivative TEI-3313. J. Pharmacol. Exp. Ther. 258:1120-26
53. Krey G, Keller H, Mahfoudi A, Medin J, Ozato K, et al. 1993. Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids. J. Steroid Biochem. Mol. Biol. 47:65-73
54. Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, et al. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528-31
55. Laudet V, Hanni C, Coll J, Catzeflis F, Stehelin D. 1992. Evolution of the nuclear receptor gene superfamily. EMBO J. 11:1003-13
56. Lee MS, Kliewer SA, Provencal J, Wright PE, Evans RM. 1993. Structure of the retinoid-X receptor-alpha DNA-binding domain: a helix required for homodimeric DNA binding. Science 260:1117-21
57. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, et al. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferates. Mol. Cell Biol 15:3012-22
58. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270:12953-56
59. Lemberger T, Braissant O, Juge-Aubry C, Keller H, Saladin R, et al. 1996a. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann. NY Acad. Sci. In press
60. Lemberger T, Saladin R, Vázquez M, Assimacopoulos F, Staels B, et al. 1996b. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271:1764-69
61. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, Wahli W. 1994. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J. Biol. Chem. 269:24527-30
62. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, et al. 1991. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352:497-505
63. Mangelsdorf DJ, Evans RM. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-50
64. Mannaerts GP, DebeerLJ, Thomas J, De Schepper PJ. 1979. Mitochondrial and peroxisomal fatty oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. J. Biol. Chem. 254:4585-95
65. Mannaerts GP, Van Veldhoven PP. 1993. Metabolic role of mammalian peroxisomes. In Peroxisomes: Biology and Importance in Toxicology and Medicine, ed. G Gibson, B Lake, pp. 19-62. London: Taylor & Francis
66. Marcus SL, Miyata KS, Zhang B, Subramani S, Rachubinski RA, Capone JP. 1993. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc. Natl. Acad. Sci. USA 90:5723-27
67. Masters C, Crane D. 1995. The Peroxisome: A Vital Organelle. pp. 150-53. Cambridge: Cambridge Univ. Press
68. McDougald OA, Lane MD. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64:345-73
69. McGarry JD. 1992. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-70
70. McGarry JD. 1995. Does leptin lighten the problem of obesity? Curr. Biol. 5:1342-44
71. Miyata KS, Zhang B, Marcus SL, Capone JP, Rachubinski RA. 1993. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated signaling. J. Biol. Chem. 268:19169-72
72. Muerhoff AS, Griffin KJ, Johnson EF. 1992. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J. Biol. Chem. 267:19051-53
73. Näär AM, Boutin JM, Lipkin SM, Yu VC, Holloway JM, et al. 1991. The orientation and spacing core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65:1267-79
74. Narumiya S, Ohno K, Fukushima M, Fujiwara M. 1987. Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei. J. Pharmacol. Exp. Ther. 242:306-11
75. Newsholme EA, Start C. 1979. Regulation in Metabolism. pp. 195-328. New York: Wiley
76. Noyori R, Suzuki M. 1993. Organic synthesis of prostaglandins: advancing biology. Science 259:44-45
77. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW. 1994. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes 43:1203-10
78. Ohta T, Azuma Y, Kanatani H, Kiyoki M, Koshihara Y. 1995. TEI-3313, a novel prostaglandin A1 derivative, prevents bone loss and enhances bone formation in immobilized male rats. J. Pharmacol. Exp. Ther. 275:450-55
79. Palmer CN, Hsu MH, Griffin HJ, Johnson EF. 1995. Novel sequence determinants in peroxisome proliferalor signaling. J. Biol. Chem. 270:16114-21
80. Peitsch MC, Jongeneel CV. 1993. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol. 5:233-38
81. Randle PJ, Kerbey AL, Espinal J. 1988. Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. Diabetes Metab. Rev. 4:623-38
82. Rastinejad F, Perlmann T, Evans RM, Sigler PB. 1995. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 375:203-11
83. Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, et al. 1995. Crystal structure of the RAR gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-89
84. Rodriguez JC, Gil-Gomez G, Hegardt FG, Haro D. 1994. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269:18767-72
85. Sandouk T, Reda D, Hofmann C. 1993. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am. J. Physiol. 264:C1600-8
86. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA. 1992. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6:1634-41
87. Schmidt A, Towler DA, Vogel R, Witherup K, Rutledge S, et al. 1994. Regulation of osteocalcin and bone sialoprotein promoters by NUCI receptor and the identification of a natural activator of NUCI. Annu. Meet. Am. Soc. Bone Min. Res. 16th, Kansas City. Abstr.
88. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, et al. 1995. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem. 270:19269-76
89. Schwabe JWR, Neuhaus D, Rhodes D. 1990. Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 348:458-61
90. Sher T, Yi HF, McBride OW, Gonzalez FJ. 1993. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32:5598-604
91. Spiegelman BM, Hotamisligil GS. 1993. Through thick and thin: wasting, obesity, and TNF alpha. Cell 73:625-27
92. Srere P. 1994. Complexities of metabolic regulation. Trends Biochem. Sci. 19:519-20
93. Steineger HH, Sørensen HN, Tugwood JD, Skrede S, Spydevold Ø, Gautvik KM. 1994. Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty-acid-induced transcription. Eur. J. Biochem. 225:967-74
94. Teboul L, Gaillard D, Staccini L, Inadera H, Amri EZ, Grimaldi PA. 1995. Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J. Biol. Chem. 270:28183-87
95. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM. 1995a. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell Biol. 15:351-57
96. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. 1994a. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8:1224-34
97. Tontonoz P, Hu E, Spiegelman BM. 1994b. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147-56
98. Tontonoz P, Hu E, Spiegelman BM. 1995b. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Gene Dev. 5:571-76
99. Tracey KJ, Cerami A. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317-43
100. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:433-39
101. Umesono K, Murakami KK, Thompson CC, Evans RM. 1991. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin-D3 receptors. Cell 65:1255-66
102. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart JC, et al. 1995. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96:741-50
103. Vu-Dac N, Schoonjans K, Laine B, Fruchart JC, Auwerx J, Staels B. 1994. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J. Biol. Chem. 269:31012-18
104. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690-97
105. Wahli W, Braissant O, Desvergne B. 1995. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem. Biol. 2:261-66
106. Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, et al. 1996. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the anti-hyperglycemic activity of thiazolidinediones. J. Med. Chem. 39:665-68
107. Winrow CJ, Marcus SL, Miyata KS, Zhang B, Capone JP, Rachubinski RA. 1994. Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4. Gene Exp. 4:53-62
108. Wu ZD, Xie YH, Bucher N, Farmer SR. 1995. Conditional ectopic expression of C/EBP-beta in NIH-3T3 cells induces PPAR-gamma and stimulates adipogenesis. Genes Dev. 9:2350-63
109. Xing GQ, Zhang LX, Zhang L, Heynen T, Yoshikawa T, et al. 1995. Rat PPAR-delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochem. Biophys. Res. Commun. 217:1015-25
110. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, et al. 1991. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113:681-87
111. Yeh WC, Cao Z, Classon M, McKnight SL. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9:168-81
112. Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, et al. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270:23975-83
113. Zhang B, Marcus SL, Miyata KS, Subramani S, Capone JP, Rachubinski RA. 1993. Characterization of protein-DNA interactions within the peroxisome proliferator-responsive element of the rat hydratase-dehydrogenase gene. J. Biol. Chem. 268:12939-45
114. Zhang B, Marcus SL, Sajjadi FG, Alvares K, Reddy JK, et al. 1992. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl. Acad. Sci. USA 89:7541-45
115. Zhu Y, Alvares K, Huang Q, Rao MS, Reddy JK. 1993. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem. 268:26817-20
116. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, et al. 1995. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc. Natl. Acad. Sci. USA 92:7921-25